Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Expert Opinion on Emerging Drugs
|
November 13, 2003
Treatments for stroke
Isabel J Beresford, Andrew A Parsons, A Jacqueline Hunter
Behavioural Brain Research
|
September 15, 2004
A behavioural characterisation of the FVB/N mouse strain
Perdita L Pugh, Sharlin F Ahmed, Martin I Smith, et al.
Diabetes
|
May 27, 2004
A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene
Ayo A Toye, Lee Moir, Alison Hugill, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 29, 2005
Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke?
Elaine A Irving, Mary Vinson, Claudia Rosin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization
Sharon Bingham, Paul J Beswick, Chas Bountra, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 7, 2002
Novel phenotypes identified by plasma biochemical screening in the mouse
Tertius A Hough, Patrick M Nolan, Vicky Tsipouri, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma
Paul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Genetica
|
December 29, 2004
Towards a mutant map of the mouse--new models of neurological, behavioural, deafness, bone, renal and blood disorders
Sohaila Rastan, Tertius Hough, Amy Kierman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Expert Opinion on Emerging Drugs
|
November 13, 2003
Treatments for stroke
Isabel J Beresford, Andrew A Parsons, A Jacqueline Hunter
Behavioural Brain Research
|
September 15, 2004
A behavioural characterisation of the FVB/N mouse strain
Perdita L Pugh, Sharlin F Ahmed, Martin I Smith, et al.
Diabetes
|
May 27, 2004
A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene
Ayo A Toye, Lee Moir, Alison Hugill, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 29, 2005
Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke?
Elaine A Irving, Mary Vinson, Claudia Rosin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization
Sharon Bingham, Paul J Beswick, Chas Bountra, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 7, 2002
Novel phenotypes identified by plasma biochemical screening in the mouse
Tertius A Hough, Patrick M Nolan, Vicky Tsipouri, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma
Paul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Genetica
|
December 29, 2004
Towards a mutant map of the mouse--new models of neurological, behavioural, deafness, bone, renal and blood disorders
Sohaila Rastan, Tertius Hough, Amy Kierman, et al.
Page
of 1